We are live on ! Find out more
TECH icon

Bio-Techne

252 hedge funds and large institutions have $3.69B invested in Bio-Techne in 2015 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 104 increasing their positions, 83 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

25% more repeat investments, than reductions

Existing positions increased: 104 | Existing positions reduced: 83

11% more capital invested

Capital invested by funds: $3.34B → $3.69B (+$352M)

4% less funds holding

Funds holding: 262252 (-10)

24% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 34

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $251K

Holders
252
Holders Change
-10
Holders Change %
-3.82%
% of All Funds
6.68%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
26
Increased
104
Reduced
83
Closed
34
Calls
Puts
$251K
Net Calls
-$251K
Net Calls Change
-$20K

TECH Hedge Fund Activity: Q1 2015 in Review

252 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2015, worth a combined $3.69B — up 11% from $3.34B a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of TECH and 26 opened new positions — a net loss of 8 holders — while 83 trimmed existing stakes and 104 added.

The largest buyer was Neuberger Berman Group, adding an estimated $31.7M. The largest seller was Renaissance Technologies, cutting an estimated $23.4M.

  • 252 institutional investors held Bio-Techne (TECH) as of Q1 2015, down from 262 in Q4 2014.
  • Funds reported $3.69B of Bio-Techne stock for Q1 2015, up 11% quarter-over-quarter.
  • 26 funds opened new Bio-Techne positions in Q1 2015 and 34 closed out, a net change of -8 holders.
  • The largest Bio-Techne buyer in Q1 2015 was Neuberger Berman Group, an estimated $31.7M added.
  • The largest Bio-Techne seller in Q1 2015 was Renaissance Technologies, an estimated $23.4M sold.

Based on aggregated 13F filings for Q1 2015.